McMaster Textbook of Internal Medicine

McMaster Textbook of Internal Medicine
Interviews
Infectious Diseases
Pending pharmacokinetic studies of antiretroviral drugs in the elderly

Pending pharmacokinetic studies of antiretroviral drugs in the elderly

2018-09-20

Philippe Morlat

Recorded at the 4th McMaster International Review Course in Internal Medicine (MIRCIM).

Are there any pending pharmacokinetic studies of antiretroviral drugs in the elderly?

Philippe Morlat, MD, PhD: Not really. The main problem in elderly patients is polypharmacy, because they take many drugs against many comorbidities. There are a lot of trials which study the interactions between antiretroviral drugs and other medications that are taken by these people, but there are no pharmacokinetic studies which are predicted.

See also

Separate TSH reference ranges for different age groups Should separate thyroid-stimulating hormone (TSH) reference ranges be determined for different age groups in the general population?
Antacids and the risk of traveler’s diarrhea Do antacids affect the risk of traveler’s diarrhea?
Antiviral drugs in HIV treatment and neuropathic pain How often is neuropathic pain caused by antiviral drugs in HIV treatment?
Medical vs regular cannabis What is medical cannabis?
Treatment of confirmed MRSA carriers among health-care workers Is a confirmed carrier status of methicillin-resistant Staphylococcus aureus (MRSA) or other drug-resistant bacteria in a health-care worker an indication for treatment? Should the worker refrain from having contact with patients?
Patients at highest risk of C difficile infection What patients are at the highest risk of developing Clostridium difficile infection?
Antibiotic resistance: how to handle in clinical practice A lecture by Prof. Mark Loeb, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.
Antiretroviral regimens in elderly patients What should we focus on when selecting an antiretroviral regimen for an elderly patient?
Strategies for controlling epidemics of HIV/AIDS What should be the main strategies to control the epidemics of HIV/AIDS?
No new cases of AIDS When could we expect no new cases of AIDS being reported in the European Union?

We would love to hear from you

Comments, mistakes, suggestions?